我们了解你们的业务

医疗保健和生命科学行业同时是一个新的边境和背景为数百万人的日常生活和福祉。行业球员处理一项不断发展的问题,因为他们努力改善人民生活的最终目标,如:

  • 由于制药公司对生物技术产品的兴趣,生命科学行业的并购活动和整合活动在经济衰退后出现了复苏。由于许多重金专利到期,大型制药公司正在为即将到来的“专利悬崖”做准备,随着公司寻找新的收入来源,并购、合资和合作的趋势应该会继续下去。我们也在供应商部门和医疗器械行业看到类似的整合。
  • 随着美国联邦和州政府各级的医疗保健成本增加,政府在减少欺诈,浪费和虐待中,政府在医疗保健系统中增加了努力。国家司法部长,卫生和人类服务的督察办公室和各种美国律师的办事处加大了他们的努力,起诉在多种欺诈和虐待的理论下起诉公司。
  • 在整个医疗保健和生命科学行业,从设施建设到研究和开发(R&D)努力的活动正受到人口和健康问题转变的推动。老年护理、肥胖和糖尿病治疗、疼痛管理、基因疗法和个性化药物继续增长。
  • 基于新的价值的偿还模型和捆绑的情节护理支付正在促进全国范围的临床一体化。实施这些结构性变化是在现有的联邦和州监管范式中挑战,这是在许多方面,与行业的整合趋势不一致。迅速变化的法律景观是必要的,由于这种改革过程在未来几年内继续进行了大量的指导。
  • 问责医疗组织(ACOs)是医疗改革方案中出现的一个热门话题,但尽管形成了ACOs,但在结构、合规程序、为医疗保健组织或患者节省成本,以及供应商部门之间的进一步合并是否会引发反垄断问题。

你的公司能取得成功吗?

我们可以帮助

由于业内近100年的综合经验,我们的医疗保健和生命科学团队的成员都是行业发展的领先优势,我们可以帮助您调整您的业务战略,以有效地抓住机遇同时避免风险。我们代表全方位的医疗保健相关业务,包括沿着护理连续体的所有提供商,托管护理组织,卫生计划,第三方管理员,提供商网络,综合交付系统,管理服务组织,管理护理公司,制造商,医疗保健技术公司,经销商,供应商,药房,制药公司,医疗器械公司,生物技术公司,风险投资公司和私募股权公司,在其监管问题和业务运营的各个方面,包括:

  • 企业服务:我们的团队拥有丰富的处理医疗服务交易,并可以帮助您提供业务规划和结构化,合同和协议,并购以及税收计划,所有人都旨在帮助您更有效和高效地运营。
  • 数据隐私和安全性:医疗保健和生命科学公司至关重要,有效地管理数据隐私和安全问题,并遵守越来越多的相关法规,最佳实践和监管机构指导。我们可以在各种问题上为您提供高度经验丰富的技术和法律顾问,从去识别临床试验数据集和患者信息,管理移动并带来自己的设备,与移动应用程序和网络感知的医疗设备一起使用符合HIPAA和HITECH,处理网站数据收集,使用和共享。我们还可以帮助预防或处理数据和安全漏洞,协助您回应政府调查,并提供有关国际数据转移遵从的指导。
  • 金融服务:医疗保健和生命科学运营需要大量的金融资本,我们的团队可以帮助您确保必要的资金来实现您的业务目标,无论您是刚刚入门还是扩大您的业务。
  • 保险:凭借医疗保健和生命科学行业面临的责任问题的普遍存在,我们可以通过有效的保险计划帮助您预测风险和保护您的兴趣。
  • 知识产权:在竞争激烈的生命科学世界中,保护您的知识产权对您的成功至关重要。我们团队的成员可以帮助您通过检察专利保护您的创新;维护您的投资组合;注册,保护和争论您的专利和谈判许可协议。
  • 国际的:我们的团队可以通过帮助您解决与您的医疗设备和产品相关的国际贸易合规问题来帮助您利用扩大全球市场。
  • 劳动力,就业和福利:我们可以帮助你管理你的公司最有价值的资产——人力资本——通过指导你通过共同就业政策等问题,培训和福利以及问题至关重要的卫生保健和生命科学产业如维护商业秘密和竞业禁止协议的实施。
  • 诉讼和争议解决在医疗保健和生命科学行业,纠纷是经常发生的,当纠纷发生时,我们的团队将迅速作出反应,维护您的利益,并寻求最理想的结果,使您可以回到业务。
  • 非营利组织和免税组织:如果您是构建作为非营利性实体的医疗保健提供者或研究组织,我们可以帮助您安全地浏览管理免税组织的不断变化的规则和规定。
  • 公共政策和监管:虽然与医疗保健和生命科学相关的公共政策往往有争议,但总是不断发展,但我们的团队对立法和监管程序有彻底的了解,可以帮助您提高您的兴趣。此外,我们还可以为您提供监管咨询,包括早期指导和建议,因此您可以实现和维护HIPAA,Hitech和实惠的护理法案等医疗保健法规的遵守情况。
  • 房地产:我们可以帮助您解决与医疗保健和生物技术运营有关的收购,开发,构建,租赁,融资和处置的独特问题。
  • 白领防御和调查:医疗保健行业的参与者面临着因欺诈和滥用指控而增加的风险和潜在的破坏性后果。我们可以通过建议您遵守联邦欺诈和滥用法规——包括《虚假申报法》、《反回扣法》、《严格的自我推荐规则》和《安全港》——来帮助您保护您的利益。如果发生指控,我们可以在美国卫生与公众服务部监察长办公室和美国司法部的执法行动以及调查中维护您的利益。

您可以信任的指导

我们彻底的知识的结合,我们丰富的经验和我们真诚的承诺提供敏感服务就是为什么客户委托我们的医疗保健和生命科学团队来处理他们的法律需求。

这些特质也是我们的团队成员在国内顶尖法律专业人士中得到认可的原因,包括领先的出版物新万博manbetx官网下载Chambers USA - 美国的主要业务律师美国最好的律师佛罗里达趋势杂志-法律精英。这些出版物基于其最优先定位的人提供的投入评论,以评估我们的能力 - 我们的客户和行业的其他律师。

我们团队赢得最近的荣誉包括:

  • Holland & Knight获得全国一流排名2021.美国新闻-最好的律师®“最佳律师事务所”卫生保健法指南,大都会一级排名在以下市场:迈阿密和塔拉哈西
  • 2020.钱伯斯美国从佛罗里达州和马萨诸塞州的荷兰和骑士合作伙伴的指导为医疗保健法。
  • 医疗保健和生命科学产业部门集团联合椅名为2020客户服务全明星由这件事BTI咨询集团
  • Holland & Knight收到最高认可美国酒吧协会的卫生法 - 年度十大律师事务所在东北部,DC和东南部排名。
  • 荷兰和骑士排名第一最大的25家医疗保健律师事务所全国范围内现代医疗保健杂志。

参观荷兰骑士医疗保健博客及时更新医疗保健欺诈和虐待,技术,健康计划,设施运营,长期护理,生命科学和公共政策。

案例研究

多媒体

Members of Holland & Knight's Public Policy & Regulation Group host a webinar covering Community Project Funding (CPF), formerly known as earmarks. Team members share insights on the new process as well as guidance on steps you can take to have your project considered.

\n

Our bipartisan group of attorneys and professionals drill down on details and programs available for the following subcommittees:

\n\n

Duration: 01:06:00

","link":{"label":"Insights and Outlook on Community Project (Earmark) Funding","url":"/en/insights/media-entities/2021/04/insights-and-outlook-on-community-project-earmark-funding","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2021/04/insights-and-outlook-on-community-project-earmark-funding","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/media_audio_still.jpg","alt":"sound waves"},"description":"

Public Policy & Regulation Group Leader Rich Gold was featured on The Political Life podcast discussing the American Rescue Plan, earmarks and expected upcoming legislation. Mr. Gold described what led to the reinstatement of earmarks, now called \"Community Project Funding,\" and offered an update on the transition to a new administration, a process that has occurred almost entirely virtually. He also talked about the status of the American Rescue Plan and previewed the next round of Congressional activity, including an infrastructure package, immigration reform and climate change-related legislation.

\n

Duration: 32:19

","link":{"label":"Rich Gold on the American Rescue Plan, the Return of Earmarks, & More","url":"/en/insights/media-entities/2021/03/rich-gold-on-the-american-rescue-plan-the-return-of-earmarks-and-more","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2021/03/rich-gold-on-the-american-rescue-plan-the-return-of-earmarks-and-more","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2021/03/media_stavinsky_jnf_still.jpg","alt":"U.S. & Israeli Innovations in the Life Sciences: Part 2"},"description":"

Israel Practice co-chair Meital Stavinsky moderated a webinar hosted by the Jewish National Fund discussing the potential COVID-19 \"cure\" Allocetra developed by Enlivex Therapeutics from Chief Scientific & Medical Officer Dror Mevorach. The panel consisted of industry professionals from the BioTech and Pharmaceutical sectors of Israel and Miami. The program also included a discussion with a Miami & Israeli BioTech Panel featuring Isaac Litman, Founder & CEO of Neteera Technologies, Dr. Osnat Sela Tavor, CTO of Nanose Medical, and Andrew Satz, CEO of EVQLV.

\n

Duration 1:26:15

","link":{"label":"U.S. & Israeli Innovations in the Life Sciences: Part 2","url":"/en/insights/media-entities/2021/03/us-israeli-innovations-in-the-life-sciences-part-2","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2021/03/us-israeli-innovations-in-the-life-sciences-part-2","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2021/02/mediafirst100dayshcstill.png","alt":"First 100 Days Title Slide"},"description":"In the first episode of our Public Policy & Regulation Group's \"The First 100 Days of the Biden Administration\" podcast series, Senior Policy Advisor Miranda Franco leads a discussion with attorney Robert Bradner and Senior Public Affairs Advisor Suzanne Joy on the healthcare priorities and landscape facing the new administration. They discuss current issues and provide listeners with an inside look on what to expect in the upcoming months.","link":{"label":"Podcast: Healthcare Priorities and Landscape","url":"/en/insights/media-entities/2021/02/podcast-healthcare-priorities-and-landscape","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2021/02/podcast-healthcare-priorities-and-landscape","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2020/09/media_crusius_multimedia_still.jpg","alt":"Eric Crusius, Partner at Holland & Knight, is interviewed on Government Matters"},"description":"

Government Contracts Partner Eric Crusius was interviewed on Government Matters about the invocation of the Defense Production Act (DPA) for vaccine distribution and impacts on contractors.

\n

\"[Defense Department agencies] have to look at whether these supplies are coming in at a rapid enough pace to get that 100 million shots in the first hundred days, plus the PPE that’s necessary, and if they feel like they’re not getting there, then it looks like DoD is on the precipice of getting DPA authorization that they haven’t had yet,\" said Mr. Crusius.

\n

Duration: 4:56

","link":{"label":"Using the Defense Production Act for Vaccine Distribution","url":"/en/insights/media-entities/2021/01/using-the-defense-production-act-for-vaccine-distribution","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2021/01/using-the-defense-production-act-for-vaccine-distribution","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2020/11/media_bgov_still.jpg","alt":"2020 Post-Election Briefing with Bloomberg Government"},"description":"

*Click \"Register\" to access the full webinar*

\n

Bloomberg Government and Holland & Knight's Public Policy & Regulation Group hosted a post-election webinar to discuss policy impacts from the 2020 elections.

\n

The panel conversations highlighted what to expect for 2021 and beyond in the areas of transportation, healthcare, energy and environment, and budget and appropriations. In addition, the panelists shared their thoughts and best practices on how to engage with the incoming administration and next Congress. 

\n

Speakers

\n

Arielle Elliott  |  President, Bloomberg Government
\nJack Fitzpatrick  |  Senior Reporter, Bloomberg Government
\nMiranda Franco  |  Senior Policy Advisor, Holland & Knight
\nMichael Friedberg  |  Partner, Holland & Knight
\nRich Gold  |  Partner, Holland & Knight
\nLauri Hettinger  |  Senior Policy Advisor, Holland & Knight
\nDimitrios Karakitsos  |  Partner, Holland & Knight
\nKellie Lunney  |  Senior Reporter, Bloomberg Government
\nHeather Rothman  |  News Director, Bloomberg Government
\nCourtney Rozen  |  Reporter, Bloomberg Government
\nAlex Ruoff  |  Senior Reporter, Bloomberg Government
\nBeth Viola  |  Senior Policy Advisor, Holland & Knight
\nShawna Watley  |  Senior Policy Advisor, Holland & Knight
\nMichael Werner  |  Partner, Holland & Knight
\nDavid Whitestone  |  Partner, Holland & Knight

\n

Duration: 1:28:49

","link":{"label":"2020 Post-Election Briefing with Bloomberg Government","url":"/en/insights/media-entities/2020/11/2020-post-election-briefing-with-bloomberg-government","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2020/11/2020-post-election-briefing-with-bloomberg-government","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2020/10/media_preelection_series_healthcare_recording_still.jpg","alt":"Pre-Election Webinar Series: Healthcare recording still"},"description":"

Holland & Knight's experienced lobbyists and attorneys are focusing on the policy implications of the upcoming 2020 elections. The fifth program in this series focused on healthcare and life sciences.

\n

Partner Michael Werner focused on issues affecting drug and biotech companies such as those relating to possible regulation of drug prices, Medicare and Medicaid reimbursement, and regulatory reforms.

\n

Partner Lisa Hawke addressed the potential for major changes to the healthcare system and the Affordable Care Act following the election, impacts on our public health, emergency preparedness and safety-net systems resulting from COVID-19, and the effects of all of these possible changes on healthcare providers and patients.

\n

View the presentation materials.

\n

Duration: 1:00:38

","link":{"label":"Election 2020: Potential Impacts Series - Healthcare & Life Sciences","url":"/en/insights/media-entities/2020/10/election-2020-potential-impacts-series-healthcare","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2020/10/election-2020-potential-impacts-series-healthcare","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/media_audio_still.jpg","alt":"sound waves"},"description":"

Healthcare and Digital Privacy Partner Shannon Hartsfield joined the DarshanTalks podcast for a discussion on the Health Insurance Portability and Accountability Act (HIPAA) and its application as digital health become more common. Their conversation covered areas such as misconceptions surrounding HIPAA's coverage, the relationship between HIPAA and similar state laws, and how healthcare providers can use digital platforms while still complying with HIPAA and other privacy requirements.

\n

Duration: 21:35

","link":{"label":"HIPAA and Digital Health Mistakes: An Interview With Shannon Hartsfield","url":"/en/insights/media-entities/2020/10/hipaa-and-digital-health-mistakes-an-interview-with-shannon-hartsfield","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2020/10/hipaa-and-digital-health-mistakes-an-interview-with-shannon-hartsfield","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2020/08/media_hhs_knocks_at_the_door_still.jpg","alt":"When HHS Knocks at the Door still"},"description":"Healthcare & Life Sciences Partners Jeremy Sternberg and Michael Manthei joined PYA for a webinar offering an overview of the CARES Act Provider Relief Fund and its reporting requirements. Although the funds function similarly to grants in that they do not require repayment, their use must be carefully documented, and audits are possible. This webinar covered the attestation requirements and areas of use, potential challenges for rural hospitals, the implications of non-compliance or false claims, and ways to demonstrate attestation made in good faith, should issues arise.
\n
\nDuration: 1:02:17","link":{"label":"When HHS Knocks at the Door — Preparing for Provider Relief Fund Attestation Defense","url":"/en/insights/media-entities/2020/08/when-hhs-knocks-at-the-door-preparing-for-provider-relief-fund","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2020/08/when-hhs-knocks-at-the-door-preparing-for-provider-relief-fund","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2020/06/mediapalmastill.jpg","alt":"Your Rights as a Medical Professional during COVID-19"},"description":"

Senior Counsel Leslie Palma participated as speaker in a webinar on medical practitioner’s rights during the COVID-19 pandemic. The session offered legal medical advice and answered many sanitary related questions for industry professionals.

\n

Duration 47:28

","link":{"label":"Your Rights as a Medical Professional During COVID-19","url":"/en/insights/media-entities/2020/06/your-rights-as-a-medical-professional-during-covid19","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2020/06/your-rights-as-a-medical-professional-during-covid19","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2020/04/bosco_elliott_robertson_media_still.jpg","alt":"Bosco_Elliott_Robertson_Media_Still"},"description":"

Partners Mary Beth Bosco, Nicole Elliott and Joel Roberson discuss the federal response to coronavirus (COVID-19) and federal funding opportunities, including the Small Business Administration Paycheck Protection Program established by the Coronavirus Aid, Relief, and Economic Security (CARES) Act.

\n

Duration: 1:01:12

","link":{"label":"Understanding the Coronavirus Emergency Loan Program for Small Businesses","url":"/en/insights/media-entities/2020/04/understanding-the-coronavirus-emergency-loan-program","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2020/04/understanding-the-coronavirus-emergency-loan-program","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/media_audio_still.jpg","alt":"sound waves"},"description":"Co-Chair of the firm's Israel Practice Meital Stavinsky spoke at the Sustainability & Digitalization Leaders (SDL) Executive Leadership Summit: Commercializing Change in Agtech. Ms. Stavinsky discussed how cannabis-tech transformed Israel from a start-up nation into an agtech nation and speculates what this means for the future of agtech in Israel. ","link":{"label":"How Cannabis-Tech Transformed Israel from a Start-Up Nation into an AgTech Nation","url":"/en/insights/media-entities/2019/10/how-cannabistech-transformed-israel","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2019/10/how-cannabistech-transformed-israel","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2019/02/avoiding-hipaa-headaches-and-hassles/videostillimage/mediastillhipaa-headaches.jpg","alt":"Avoiding HIPAA Headaches and Hassles"},"description":"

All healthcare lawyers need to know about HIPAA and how it affects the healthcare industry. In this program, attorneys Shannon Hartsfield and Eddie Williams will talk about key HIPAA concepts that every lawyer should know. Along with key concepts, there are some areas that can be sticky and have compliance pitfalls. The attorneys will address those areas and how to overcome or avoid them for your clients. Recent regulatory developments have taken shape regarding HIPAA and the presenters will cover those here for you.

Duration: 1 hour 6 minutes

","link":{"label":"Avoiding HIPAA Headaches and Hassles","url":"/en/insights/media-entities/2019/02/avoiding-hipaa-headaches-and-hassles","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2019/02/avoiding-hipaa-headaches-and-hassles","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2018/11/midterm-post-election-briefing-2018/videostillimage/mediapostelectionbriefingstill.jpg","alt":"Midterm Post Election Briefing 2018"},"description":"

Bloomberg Government and Holland & Knight's Public Policy & Regulation Group presented a live stream of our post-election briefing, during which panelists provided in-depth analysis of the 2018 midterm elections results. During the program, our featured panelists explored what the results might mean for key industry sectors, including trade, infrastructure and transportation, energy and environment, and healthcare and life sciences.

View the slides from the program and follow the conversation on Twitter with #askBGOVHK.

What Happened in 2018?

\"\"
Watch the video »

  • Greg Giroux, Reporter, Bloomberg Government

Transportation and Infrastructure

\"\"
Watch the video »

  • Heather Rothman, News Director, Bloomberg Government 
  • Shaun Courtney, Federal Transportation Reporter, Bloomberg Government 
  • Michael Friedberg, Senior Counsel, Holland & Knight 
  • Shawna Francis Watley, Senior Policy Advisor, Holland & Knight

Healthcare/Pharmaceuticals

\"\"
Watch the video »

  • Heather Rothman, News Director, Bloomberg Government
  • Alex Ruoff, Health Policy Reporter, Bloomberg Government
  • Michael Werner, Partner, Holland & Knight
  • Miranda Franco, Senior Policy Advisor, Holland & Knight

Energy and Environment

 \"\"
Watch the video »

  • Abby Smith, Reporter, Bloomberg Environment 
  • Dimitrios Karakitsos, Partner, Holland & Knight 
  • Benjamin Dunham, Senior Policy Advisor, Holland & Knight

Trade and Tariffs

\"\"
Watch the video »

  • Loren Duggan, Editorial Director, Bloomberg Government 
  • Sarah Babbage, Legislative Analyst, Bloomberg Government 
  • Ronald Oleynik, Partner, Holland & Knight 
  • Jim Davis, Partner, Holland & Knight
","link":{"label":"Midterm Post Election Briefing 2018","url":"/en/insights/media-entities/2018/11/midterm-post-election-briefing-2018","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2018/11/midterm-post-election-briefing-2018","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2018/10/a-preview-of-the-fbas-qui-tam-2019-conference/videostillimage/mediafbaquitam2019conferencestill.jpg","alt":"A Preview of the FBA's \"Qui Tam 2019\" Conference"},"description":"

Partner Megan Jeschke is a co-chair of the Federal Bar Association (FBA)'s \"Qui Tam 2019\" conference. Ms. Jeschke and co-chair Darrell Valdez, Assistant U.S. Attorney, District of Columbia, spoke with R. Scott Oswald, Chair of the FBA's Qui Tam Section on what will be discussed at the Qui Tam 2019 conference as well as potential panel topics such as litigation, settlement, subjectivity issues and mediation. In closing, the conference will bring in opioid crisis subject matter experts to use the panel topics to review a case on fraud in the opioid space.

Duration: 12:45

","link":{"label":"A Preview of the FBA's \"Qui Tam 2019\" Conference","url":"/en/insights/media-entities/2018/10/a-preview-of-the-fbas-qui-tam-2019-conference","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2018/10/a-preview-of-the-fbas-qui-tam-2019-conference","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2017/11/what-the-fdas-new-framework-means-for-regenerative/videostillimage/mediaaudiostill.jpg","alt":"What the FDA's New Framework Means for Regenerative Therapies"},"description":"

The FDA recently passed a new policy framework governing the development and oversight of regenerative medicine. Attorney Michael Werner discussed these new policies and what they mean for the industry at large on an episode of RARECast.

Duration: 27:20

","link":{"label":"What the FDA's New Framework Means for Regenerative Therapies","url":"/en/insights/media-entities/2017/11/what-the-fdas-new-framework-means-for-regenerative","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2017/11/what-the-fdas-new-framework-means-for-regenerative","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2017/06/straight-from-the-cutters-mouth-a-retina-podcast/videostillimage/mediaaudiostill.jpg","alt":"Straight from the Cutter’s Mouth: A Retina Podcast"},"description":"

On this Retina Podcast, Litigation Attorneys Joshua Levenson and Ben Taormina, discuss various legal matters including medical malpractice, the importance of accurate documentation in the medical record and employment contracts.

Duration: 40:34

","link":{"label":"Straight from the Cutter’s Mouth: A Retina Podcast","url":"/en/insights/media-entities/2017/06/straight-from-the-cutters-mouth-a-retina-podcast","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2017/06/straight-from-the-cutters-mouth-a-retina-podcast","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2016/11/an-overview-of-what-to-expect-from-the-trump-admin/videostillimage/mediatrumpadministrationwebinarstill.jpg","alt":"An Overview of What to Expect From the Trump Administration"},"description":"

With a new presidential administration on the horizon, Holland & Knight presents an overview of what to expect from the incoming Trump Administration and the first session of the 115th Congress, including issues ranging from energy, taxation, environment, healthcare and local governments.

\n

Our senior lobbyists and lawyers provide analysis and respond to questions. In what is sure to be a year of change and historical importance, set your policy direction with the aid and insight of Holland & Knight's seasoned professionals in this webinar presentation.

\n

View the program materials.

\n

Duration 2 hrs and 44 minutes

","link":{"label":"An Overview of What to Expect From the Trump Administration","url":"/en/insights/media-entities/2016/11/an-overview-of-what-to-expect-from-the-trump-admin","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2016/11/an-overview-of-what-to-expect-from-the-trump-admin","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2016/08/stem-cell-treatment-promised-by-clinics-but-has-it/videostillimage/mediaaudiostill.jpg","alt":"Stem Cell Treatment Promised by Clinics, but Has It Been Proven?"},"description":"As stem-cell research booms, mainstream scientists say it will be years before these types of therapies are proven safe and effective. The Wall Street Journal's Melinda Beck explains on Lunch Break with Tanya Rivero along with Holland & Knight Partner and Alliance for Regenerative Medicine's Michael Werner.","link":{"label":"Stem Cell Treatment Promised by Clinics, but Has It Been Proven?","url":"/en/insights/media-entities/2016/08/stem-cell-treatment-promised-by-clinics-but-has-it","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2016/08/stem-cell-treatment-promised-by-clinics-but-has-it","target":"","rel":""}},{"image":{"url":"/-/media/images/insights/media-entities/2011/05/cms-fda-and-the-parallel-review-process/videostillimage/mediacmsfdastill.jpg","alt":"CMS, FDA and the “Parallel Review Process”"},"description":"

VIEW WEBCAST
Duration: 8 min.

Drug companies and medical device manufacturers must do their homework before undergoing a “parallel review process” of the Food and Drug Administration and the Center for Medicare & Medicaid Services. That’s what Partner Michael Gaba, leader of the firm’s national Healthcare and Life Sciences Team, notes in a webinar about the new joint review system created by the two agencies.

Originally recorded as part of the Bureau of National Affair’s “Thought Leadership” video series, Mr. Gaba says one hurdle for companies to overcome is the agencies’ different missions and styles of review. “The FDA, by its nature, reviews products in a very confidential manner, maintaining the proprietary status of the information submitted by companies,” Mr. Gaba says. “CMS, by comparison, when undertaking a coverage process, does so in a very public manner.”

Mr. Gaba also discusses if the parallel review process can shorten the time for a product to go to market, and whether it can spur venture capital investment in innovative technologies.

Note: Reproduced with permission from the Bureau of National Affairs, \"BNA Insights Health Care,\" BNA Video Insights. Copyright 2011 by The Bureau of National Affairs, Inc. (800-372-1033) www.bna.com

","link":{"label":"CMS, FDA and the “Parallel Review Process”","url":"/en/insights/media-entities/2011/05/cms-fda-and-the-parallel-review-process","AbsoluteUrl":"//www.efaxnow.com/en/insights/media-entities/2011/05/cms-fda-and-the-parallel-review-process","target":"","rel":""}}]">

出版物

Holland & Knight Alert"],"link":{"label":"Healthcare Law Update: April 2021","url":"/en/insights/publications/2021/04/healthcare-law-update-april-2021","AbsoluteUrl":"//www.efaxnow.com/en/insights/publications/2021/04/healthcare-law-update-april-2021","target":"","rel":""},"icon":{"url":"/-/media/images/icons/articleicon__doctor.svg","alt":"Doctor"},"image":{"url":null,"alt":null},"date":"April 16, 2021","readingtime":"16 Minutes","source":null},{"metaData":["Holland & Knight Alert"],"link":{"label":"DOL Releases Guidance and Model Notices for New COBRA Premium Subsidy","url":"/en/insights/publications/2021/04/dol-releases-guidance-and-model-notices-for-new-cobra-premium-subsidy","AbsoluteUrl":"//www.efaxnow.com/en/insights/publications/2021/04/dol-releases-guidance-and-model-notices-for-new-cobra-premium-subsidy","target":"","rel":""},"icon":{"url":null,"alt":null},"image":{"url":null,"alt":null},"date":"April 13, 2021","readingtime":"4 Minutes","source":null},{"metaData":["Holland & Knight Alert"],"link":{"label":"American Jobs Plan of 2021: Summary","url":"/en/insights/publications/2021/04/american-jobs-plan-act-of-2021-summary","AbsoluteUrl":"//www.efaxnow.com/en/insights/publications/2021/04/american-jobs-plan-act-of-2021-summary","target":"","rel":""},"icon":{"url":"/-/media/images/icons/capital.png","alt":"Capital Building"},"image":{"url":null,"alt":null},"date":"April 1, 2021","readingtime":"3 Minutes","source":null},{"metaData":["Holland & Knight Alert"],"link":{"label":"Illinois Legislature Submits Revised and Amended Prejudgment Interest Bill","url":"/en/insights/publications/2021/03/illinois-legislature-submits-revised-and-amended-prejudgment-interest","AbsoluteUrl":"//www.efaxnow.com/en/insights/publications/2021/03/illinois-legislature-submits-revised-and-amended-prejudgment-interest","target":"","rel":""},"icon":{"url":null,"alt":null},"image":{"url":null,"alt":null},"date":"March 31, 2021","readingtime":"4 Minutes","source":null},{"metaData":["Holland & Knight Alert"],"link":{"label":"COBRA Premium Subsidy Under the American Rescue Plan Act","url":"/en/insights/publications/2021/03/cobra-premium-subsidy-under-the-american-rescue-plan-act","AbsoluteUrl":"//www.efaxnow.com/en/insights/publications/2021/03/cobra-premium-subsidy-under-the-american-rescue-plan-act","target":"","rel":""},"icon":{"url":null,"alt":null},"image":{"url":null,"alt":null},"date":"March 30, 2021","readingtime":"6 Minutes","source":null},{"metaData":["Holland & Knight Alert"],"link":{"label":"Can the Private Sector Prefer Vaccinated Consumers or Exclude the Unvaccinated?","url":"/en/insights/publications/2021/03/can-the-private-sector-prefer-vaccinated-consumers-or-exclude","AbsoluteUrl":"//www.efaxnow.com/en/insights/publications/2021/03/can-the-private-sector-prefer-vaccinated-consumers-or-exclude","target":"","rel":""},"icon":{"url":"/-/media/images/icons/articleicon__doctor.svg","alt":"Doctor"},"image":{"url":null,"alt":null},"date":"March 26, 2021","readingtime":"8 Minutes","source":null}]">

接下来的活动

新闻和标题

South Florida Sun-Sentinel","In the Headlines"],"link":{"label":"Going Back To The Office? How Most Employers Are Handling COVID Vaccines For Workers","url":"/en/news/intheheadlines/2021/04/going-back-to-the-office-how-most-employers-are-handling-vaccines","AbsoluteUrl":"//www.efaxnow.com/en/news/intheheadlines/2021/04/going-back-to-the-office-how-most-employers-are-handling-vaccines","target":"","rel":""},"icon":{"url":null,"alt":null},"image":null,"date":"April 14, 2021","readingtime":null,"source":null},{"metaData":["","","Press Release"],"link":{"label":"Holland & Knight Advises Kashiv Biosciences in Sale of Specialty Pharmaceuticals Unit to Amneal Pharmaceuticals","url":"/en/news/pressreleases/2021/04/holland-knight-advises-kashiv-biosciences-in-sale","AbsoluteUrl":"//www.efaxnow.com/en/news/pressreleases/2021/04/holland-knight-advises-kashiv-biosciences-in-sale","target":"","rel":""},"icon":{"url":null,"alt":null},"image":null,"date":"April 8, 2021","readingtime":null,"source":null},{"metaData":["","Law360","In the Headlines"],"link":{"label":"Fla. Gov. Signs Sweeping COVID-19 Liability Protection Law","url":"/en/news/intheheadlines/2021/03/fla-gov-signs-sweeping-covid19-liability-protection-law","AbsoluteUrl":"//www.efaxnow.com/en/news/intheheadlines/2021/03/fla-gov-signs-sweeping-covid19-liability-protection-law","target":"","rel":""},"icon":{"url":"/-/media/images/icons/articleicon__doctor.svg","alt":"Doctor"},"image":null,"date":"March 30, 2021","readingtime":null,"source":null}]">